Resistin G–A haplotype at SNP‐420/‐358 is associated with the latent sarcopenic obesity index in the toon genome study

AIM/INTRODUCTION Resistin, which induces insulin resistance, is mainly expressed in monocytes/macrophages in humans. We reported previously that serum resistin was highest in the G-A haplotype defined by resistin single nucleotide polymorphisms (SNPs) at -420 (rs1862513) and - 358 (rs3219175). As sarcopenic obesity is associated with insulin resistance, we aimed to examine whether serum resistin and its haplotypes were associated with sarcopenic obesity at a latent stage. MATERIALS AND METHODS We cross-sectionally analyzed 567 community-dwelling Japanese participants attending annual medical check-ups in which the sarcopenic obesity index was evaluated. The age- and gender-matched normal glucose tolerance subjects with G-A homozygotes and those with C-G homozygotes were examined via RNA-sequencing and pathway analysis (each n = 3), and RT-PCR (each n = 8). RESULTS In multivariate logistic regression analyses, the fourth quartile (Q4) of serum resistin and G-A homozygotes were both associated with the latent sarcopenic obesity index defined by a visceral fat area of ≥ 100 cm2 and grip strength Q1 after adjustment for age and gender, with or without other confounding factors. RNA sequencing and pathway analysis showed that tumor necrosis factor (TNF) was involved in the top five pathways in the whole blood cells of G-A homozygotes compared with C-G homozygotes. RT-PCR revealed that TNF mRNA was higher in G-A homozygotes than in C-G homozygotes. CONCLUSIONS The G-A haplotype was associated with the latent sarcopenic obesity index defined by grip strength in the Japanese cohort, could be mediated by TNF-α.

[1]  Toshiko Tanaka,et al.  Genome-wide meta-analysis of muscle weakness identifies 15 susceptibility loci in older men and women , 2020, Nature Communications.

[2]  René Rizzoli,et al.  Sarcopenia: revised European consensus on definition and diagnosis , 2018, Age and ageing.

[3]  M. Yano,et al.  Elevated serum adiponectin and tumor necrosis factor-α and decreased transthyretin in Japanese elderly women with low grip strength and preserved muscle mass and insulin sensitivity , 2018, BMJ Open Diabetes Research & Care.

[4]  Y. Tabara,et al.  An inverse association between serum resistin levels and n‐3 polyunsaturated fatty acids intake was strongest in the SNP‐420 G/G genotype in the Japanese cohort: The Toon Genome Study , 2018, Clinical endocrinology.

[5]  N. Kato,et al.  Genome-wide association study of plasma resistin levels identified rs1423096 and rs10401670 as possible functional variants in the Japanese population. , 2016, Physiological genomics.

[6]  M. Budoff,et al.  The association of resistin with cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis. , 2015, Atherosclerosis.

[7]  Jose M Garcia,et al.  Sarcopenia, Cachexia and Aging: Diagnosis, Mechanisms and Therapeutic Options - A Mini-Review , 2014, Gerontology.

[8]  L. Peng,et al.  Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. , 2014, Journal of the American Medical Directors Association.

[9]  Peter H Whincup,et al.  Sarcopenic Obesity and Risk of Cardiovascular Disease and Mortality: A Population-Based Cohort Study of Older Men , 2014, Journal of the American Geriatrics Society.

[10]  Y. H. Kim,et al.  Sarcopenia and sarcopenic obesity and their association with dyslipidemia in Korean elderly men: the 2008–2010 Korea National Health and Nutrition Examination Survey , 2014, Journal of Endocrinological Investigation.

[11]  J. G. Lee,et al.  Sarcopenic obesity as an independent risk factor of hypertension. , 2013, Journal of the American Society of Hypertension : JASH.

[12]  H. J. Yoo,et al.  Relationships between sarcopenic obesity and insulin resistance, inflammation, and vitamin D status: the Korean Sarcopenic Obesity Study , 2013, Clinical endocrinology.

[13]  Todd M Manini,et al.  Dynapenia and aging: an update. , 2012, The journals of gerontology. Series A, Biological sciences and medical sciences.

[14]  M. Delmonico,et al.  Age-related changes in adult muscle morphology. , 2011, Current aging science.

[15]  A. Karlamangla,et al.  Relative muscle mass is inversely associated with insulin resistance and prediabetes. Findings from the third National Health and Nutrition Examination Survey. , 2011, The Journal of clinical endocrinology and metabolism.

[16]  K. Kohara,et al.  A at Single Nucleotide Polymorphism-358 Is Required for G at -420 to Confer the Highest Plasma Resistin in the General Japanese Population , 2010, PloS one.

[17]  T. Ninomiya,et al.  Diabetes and hypertension markedly increased the risk of ischemic stroke associated with high serum resistin concentration in a general Japanese population: the Hisayama Study , 2009, Cardiovascular diabetology.

[18]  C. Fox,et al.  Association of Variants in RETN With Plasma Resistin Levels and Diabetes-Related Traits in the Framingham Offspring Study , 2009, Diabetes.

[19]  Brian H Chen,et al.  Circulating Levels of Resistin and Risk of Type 2 Diabetes in Men and Women: Results From Two Prospective Cohorts , 2009, Diabetes Care.

[20]  A. Rossi,et al.  Sarcopenic obesity: a new category of obesity in the elderly. , 2008, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[21]  B. Clark,et al.  Sarcopenia =/= dynapenia. , 2008, The journals of gerontology. Series A, Biological sciences and medical sciences.

[22]  Joan Valls,et al.  SNPStats: a web tool for the analysis of association studies , 2006, Bioinform..

[23]  M. Molinaro,et al.  Tumor necrosis factor‐α gene transfer induces cachexia and inhibits muscle regeneration , 2005 .

[24]  Y. Tabara,et al.  Resistin SNP-420 determines its monocyte mRNA and serum levels inducing type 2 diabetes. , 2005, Biochemical and biophysical research communications.

[25]  Anil Kumar Singh,et al.  Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway. , 2005, Biochemical and biophysical research communications.

[26]  Kazuya Yamada,et al.  The G/G genotype of a resistin single-nucleotide polymorphism at -420 increases type 2 diabetes mellitus susceptibility by inducing promoter activity through specific binding of Sp1/3. , 2004, American journal of human genetics.

[27]  M. Lazar,et al.  The current biology of resistin , 2004, Journal of internal medicine.

[28]  Joanna D. Holbrook,et al.  Resistin is expressed in human macrophages and directly regulated by PPARγ activators , 2003 .

[29]  Robert Ross,et al.  Low Relative Skeletal Muscle Mass (Sarcopenia) in Older Persons Is Associated with Functional Impairment and Physical Disability , 2002, Journal of the American Geriatrics Society.

[30]  H. Onuma,et al.  Systematic search for single nucleotide polymorphisms in the resistin gene: the absence of evidence for the association of three identified single nucleotide polymorphisms with Japanese type 2 diabetes. , 2002, Diabetes.

[31]  M. Lazar,et al.  The hormone resistin links obesity to diabetes , 2001, Nature.

[32]  R. Baumgartner Body Composition in Healthy Aging , 2000, Annals of the New York Academy of Sciences.